SCHEMBL7419218

SCHEMBL7419218

CCOC(=O)Cc1cc2cc(C)ccc2o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.46
CA12 O43570 2/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 2/20 0.46
CA6 P23280 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
CA5B Q9Y2D0 2/20 0.46
CA1 P00915 1/20 0.46
CA5A P35218 1/20 0.46
TAS1R3 Q7RTX0 3/20 0.44
TAS1R1 Q7RTX1 3/20 0.44
MAOA P21397 2/20 0.43
ALDH1A1 P00352 2/20 0.41
MMP2 P08253 2/20 0.41
ADAM17 P78536 2/20 0.41
MMP9 P14780 1/20 0.41
CA3 P07451 1/20 0.41
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13790848 0.87 MAOB (0.58) MAOBMAOAALDH1A1KDM4EHPGD
SCHEMBL20799424 0.86 TP53 (0.48) MAOBTAS1R3TAS1R1ALDH1A1RAB9A
SCHEMBL13791154 0.85 MAOB (0.60) MAOBCA12CA2CA4CA6
SCHEMBL5947962 0.84 MAOB (0.52) MAOBMAOAALDH1A1RAB9AKDM4E
SCHEMBL1066982 0.76 TAS1R3 (0.56) MAOBCA12CA2CA4CA6
SCHEMBL11559549 0.76 MAOB (0.49) MAOBCA12CA2CA4CA6
SCHEMBL24766804 0.74 GAA (0.49) ALDH1A1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL9430490 0.74 MAOB (0.49) MAOBCA12CA2CA4CA6
SCHEMBL17996501 0.73 TAS1R3 (0.53) MAOBCA12CA2CA4CA6
SCHEMBL9204717 0.73 MAOB (0.46) MAOBCA12CA2CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5789415-A Azacyclic-heterocyclic compounds as angiotension II receptor antagonists PFIZER INC. (US) 1998-08-04 US disclosed
WO-1995002596-A1 AZACYCLIC-HETEROCYCLIC COMPOUNDS AS ANGIOTENSIN II RECEPTOR ANTAGONISTS PFIZER INC. (US) 1995-01-26 WO disclosed